The United States will invest one billion dollars to develop key components for a swine fluvaccine and conduct clinical studies into its efficacy, Health Secretary Kathleen Sebelius said.The money will come from already existing funds and will be used to place orders with companies licensed to produce flu vaccine for antigens -- the ingredient in a vaccine that causes the body to develop antibodies -- and adjuvants, which boost the body's immune response.Healthy mind and actions are taking today will help us be prepared if a vaccine is needed.
Comment Reply
The United States will invest one billion dollars to develop key components for a swine fluvaccine and conduct clinical studies into its efficacy, Health Secretary Kathleen Sebelius said.The money will come from already existing funds and will be used to place orders with companies licensed to produce flu vaccine for antigens -- the ingredient in a vaccine that causes the body to develop antibodies -- and adjuvants, which boost the body's immune response.Healthy mind and actions are taking today will help us be prepared if a vaccine is needed.
June 8, 2009 - 9:53pmThis Comment
Reply